Skip to the main content
The Crier

Sequencing Technologies in Clinical Research

Your saved contracts

What the buyer wrote

Nanopore-based sequencing has become a highly effective next generation sequencing tool for biological research. Nanopore sequencing converts the electrical signals generated by a nucleotide strand (either DNA or RNA) passing through the nanopore into the base sequence. This methodology was exclusively commercialized by Oxford Nanopore Technologies, allowing sequencing of long reads with real-time sequence detection and analysis. It can also provide base modification detection. The technique has short sample preparation times with low instrument costs. The technology is a relatively new, rapidly expanding and groundbreaking, with ~79% of nanopore-related literature published within the las…

Read all of it on Find a Tender →

Bid for this and lost? There is a short window in which the decision can be questioned.

Details

What the buyer calls it
Sequencing Technologies in Clinical Research
How they are buying
Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
Type
goods
Where
in the West Midlands

Who the buyer named

Pauline Harrison-Johnson was the named contact on this notice.

P.E.Harrison@bham.ac.uk